Pharmaceutical Pricing: A Review Of Proposals To Improve Access And Affordability Of Prescription Drugs,
2010
American Dental Association
Pharmaceutical Pricing: A Review Of Proposals To Improve Access And Affordability Of Prescription Drugs, Paula Tironi
Annals of Health Law and Life Sciences
This article discusses how pharmaceutical innovation achieves remarkable improvements in human health but a significant portion of the U.S. population cannot afford prescription drugs. The author examines ways that patent protection, generics, supply chain complexity, and the cost of innovation and promotion affect access and affordability. The author then looks at the influences of marketing strategies and industry trends such as the patent cliff and pipeline for new drugs, innovations in biotechnology and genomics, comparative effectiveness analysis, and payor and employer strategies on drug prices. An analysis of reform proposals in the context of industry trends suggests that promoting generic …
A Call For Minds: The Unknown Extent Of Societal Influence On The Legal Rights Of Involuntarily And Voluntarily Committed Mental Health Patients,
2010
University of Illinois College of Law
A Call For Minds: The Unknown Extent Of Societal Influence On The Legal Rights Of Involuntarily And Voluntarily Committed Mental Health Patients, Teresa Cannistraro
Annals of Health Law and Life Sciences
This article begins and ends with a call for more empirical research to understand the connection between societal views of mental illness and the legal system. The author asserts that changing social perceptions of mental illness certainly affect legal outcomes and commitment levels, but the degree remains unknown. This article explores the above two topics through the framework of the Circuit Court 'split' regarding the Constitutional rights of persons committed to state mental health institutions. A main facet of the 'split' is centered on the Circuits' disagreement about whether or not all mentally ill patients committed to institutions deserve the …
Government-Sponsored Reinsurance,
2010
Wake Forest University
Government-Sponsored Reinsurance, Mark A. Hall
Annals of Health Law and Life Sciences
Many measures to reform health insurance markets include various types of government-sponsored reinsurance. This article explains the purposes and types of private and public reinsurance, and reviews available evidence about their performance. The author concludes that government-sponsored reinsurance inherently cannot reduce total costs, but it can shift costs from the private to the public sector. Also, reinsurance can help transition to a new government program or market structure that creates uncertain risks. Whether reinsurance is the best way to accomplish these goals depends greatly on the details.
Table Of Contents,
2010
Loyola University Chicago, School of Law
Table Of Contents, Annals Of Health Law
Annals of Health Law and Life Sciences
No abstract provided.
Foreword,
2010
Loyola University Chicago, School of Law
Foreword, Kendell L. Coker, Lawrence Singer, John Blum
Annals of Health Law and Life Sciences
No abstract provided.
Rationing Health Care: It's A Matter Of The Health Care System's Structure,
2010
Indiana University School of Law-Indianapolis
Rationing Health Care: It's A Matter Of The Health Care System's Structure, David Orentlicher
Annals of Health Law and Life Sciences
The article examines two primary policy proposals for how the U.S. should allocate its limited health care dollars: a centralized model in which a commission establishes rationing guidelines, and a decentralized model in which rationing decisions are made by health care providers on a case by case basis. The author finds significant advantages with each position, leading the author to assert that a combination of each is key to an effective rationing policy: a centralized control of structure coupled with decentralized physician-level decision making. While mindful that formal rationing guidelines alone are unfeasible to effectuate cost-effective care, the author introduces …
Retail Medical Clinics: Increasing Access To Low Cost Medical Care Amongst A Developing Legal Environment,
2010
American Medical Association
Retail Medical Clinics: Increasing Access To Low Cost Medical Care Amongst A Developing Legal Environment, Kristin E. Schleiter
Annals of Health Law and Life Sciences
No abstract provided.
Reproductive Organs And Differences Of Sex Development: The Constitutional Issues Created By The Surgical Treatment Of Intersex Children,
2010
University of the Pacific, McGeorge School of Law
Reproductive Organs And Differences Of Sex Development: The Constitutional Issues Created By The Surgical Treatment Of Intersex Children, Skylar Curtis
McGeorge Law Review
No abstract provided.
A Bitter Pill To Swallow: Canadian Drug Regulation,
2010
Schulich School of Law, Dalhousie University
A Bitter Pill To Swallow: Canadian Drug Regulation, Michael Duncan Taylor
LLM Theses
This thesis assesses the current status of Canadian prescription drug regulation and the policy drivers that guide this process. This analysis is accomplished by first providing a general survey of the steps, law, and institutional players involved in the full life-cycle of a drug. Next the evolution of current clinical trials and the gaps that the present legal regime creates in the scientific standards employed in clinical research is reviewed. This is followed by a discussion of how commercialization (innovation) and speed of approval (market access) are slowly becoming the dominant policy drivers for the Canadian regime. Finally a discussion …
There Is A Time To Keep Silent And A Time To Speak, The Hard Part Is Knowing Which Is Which: Striking The Balance Between Privacy Protection And The Flow Of Health Care Information,
2010
Federal Trade Commission
There Is A Time To Keep Silent And A Time To Speak, The Hard Part Is Knowing Which Is Which: Striking The Balance Between Privacy Protection And The Flow Of Health Care Information, Daniel J. Gilman, James C. Cooper
Michigan Telecommunications & Technology Law Review
Health information technology (HIT) has become a signal element of federal health policy, especially as the recently enacted American Recovery and Reinvestment Act of 2009 (Recovery Act or ARRA) comprises numerous provisions related to HIT and commits tens of billions of dollars to its development and adoption. These provisions charge various agencies of the federal government with both general and specific HIT-related implementation tasks including, inter alia, providing funding for HIT in various contexts: the implementation of interoperable HIT, HIT-related infrastructure, and HIT-related training and research. The Recovery Act also contains various regulatory provisions pertaining to HIT. Provisions of the …
Oversight Of Marketing Relationships Between Physicians And The Drug And Device Industry: A Comparative Study,
2010
Washington and Lee University School of Law
Oversight Of Marketing Relationships Between Physicians And The Drug And Device Industry: A Comparative Study, Timothy Stoltzfus Jost
Scholarly Articles
Throughout the world, complex mutually-dependent relationships exist between physicians and pharmaceutical and medical device companies. This articlef ocuses on one particulara spect of these relationships--paymentsm ade by drug and device companies to physicians and their organizations and institutions to market drugs and devices. It is widely believed that drug and device company marketing to physicians creates conflicts of interest that corrupt physician judgment and increase the cost of medical care. This article examines first the economic basis of physician/industry relationships that causes conflicts to arise. It next considers the measures that a number of developed countries have taken to respond …
Foreword,
2010
Loyola University Chicago, School of Law
Foreword, Beazley Institute For Health Law And Policy
Annals of Health Law and Life Sciences
No abstract provided.
Towards Achieving Lasting Healthcare Reform: Rethinking The American Social Contract,
2010
University of Georgia School of Law
Towards Achieving Lasting Healthcare Reform: Rethinking The American Social Contract, Fazal Khan
Annals of Health Law and Life Sciences
No abstract provided.
Genetic Testing, Physicians And The Law: Will The Tortoise Ever Catch Up With The Hare,
2010
Loyola University Chicago, School of Law
Genetic Testing, Physicians And The Law: Will The Tortoise Ever Catch Up With The Hare, Lee Black, Jaques Simard, Bartha Maria Knoppers
Annals of Health Law and Life Sciences
No abstract provided.
Emergence And Re-Emergence Of H1n1 Influenza: Uncanny Parallels Between The Administrations Of U.S. Presidents Woodrow Wilson And Barack Obama,
2010
Loyola University Chicago, School of Law
Emergence And Re-Emergence Of H1n1 Influenza: Uncanny Parallels Between The Administrations Of U.S. Presidents Woodrow Wilson And Barack Obama, Sandra Anderson-Guerra Sosa, Adriane Johnson
Annals of Health Law and Life Sciences
No abstract provided.
Finding A New Regulatory Pathway For The Old Labyrinth Of Health Planning,
2010
Loyola University Chicago, School of Law
Finding A New Regulatory Pathway For The Old Labyrinth Of Health Planning, John D. Blum
Annals of Health Law and Life Sciences
No abstract provided.
Medical Research Regulation After More Than Twenty-Five Years: Old Problems, New Challenges, And Regulatory Imbalance,
2010
University of North Carolina School of Law
Medical Research Regulation After More Than Twenty-Five Years: Old Problems, New Challenges, And Regulatory Imbalance, Richard S. Saver
Annals of Health Law and Life Sciences
No abstract provided.
Fee-For-Disservice: Medicare Fraud In The Home Healthcare Industry,
2010
Loyola University Chicago, School of Law
Fee-For-Disservice: Medicare Fraud In The Home Healthcare Industry, Brooke Benzio
Annals of Health Law and Life Sciences
No abstract provided.
The Death Of Jesse Gelsinger: New Evidence Of The Influence Of Money And Prestige In Human Research,
2010
Washington and Lee University School of Law
The Death Of Jesse Gelsinger: New Evidence Of The Influence Of Money And Prestige In Human Research, Robin Fretwell Wilson
Scholarly Articles
Ten years ago, Jesse Gelsinger died while participating in a human gene therapy trial at the University of Pennsylvania (“Penn”). His death came to signify the corrosive influence of financial interests in human subjects research. After Jesse's death, the media reported that one researcher. Dr. James Wilson, held shares in a biotech company, Genovo, which stood to gain from the research's outcome — shares that The Wall Street Journal later valued at $13.5 million, although Wilson maintains he did not make nearly this much. At the time Penn authorized Wilson's deal, internal Penn documents implicitly valued Wilson's stake in Genovo …
Preemption And The Public Health: How Wyeth V. Levine Stands To Change The Ways In Which We Implement Health Policy,
2010
Saint Louis University School of Law
Preemption And The Public Health: How Wyeth V. Levine Stands To Change The Ways In Which We Implement Health Policy, Shane Levesque
Saint Louis University Journal of Health Law & Policy
No abstract provided.
